US research roundup: 3M, C4 Therapeutics and PepsiCo
MMM•Analysts revised ratings and price targets for several U.S.-listed companies. JP Morgan cut 3M’s target to $185 from $205, initiated C4 Therapeutics at overweight with a $10 target, and Deutsche Bank cut PepsiCo’s target to $132 from $138.
1. Selected analyst actions
JP Morgan cut its price target for 3M to $185 from $205 and initiated coverage of C4 Therapeutics with an overweight rating and a $10 target. Deutsche Bank lowered its PepsiCo target to $132 from $138. Other highlighted moves included Scotiabank cutting AT&T’s target to $26.50 from $27.50 and Barclays cutting Edison International’s target to $53 from $75.
